Fosrenol Post-marketing Surveillance for Hemodialysis in Japan

Share this article:
Fosrenol Post-marketing Surveillance for Hemodialysis in Japan

Sponsor and Collaborators
Bayer

Contact
Bayer Clinical Trials
clinical-trials-contact@bayerhealthcare.com

Study Director
Bayer Study Director

ClinicalTrials.gov Identifier
NCT01419327
Share this article:
You must be a registered member of RUN to post a comment.

Sign Up for Free e-newsletters

More in Hyperphosphatemia Clinical Trials

Dose Finding Study to Treat High Phosphate Levels in the Blood

A look at the following clinical trial: Dose Finding Study to Treat High Phosphate Levels in the Blood.

Safety and Tolerability Study of MCI-196

A look at the following clinical trial: Safety and Tolerability Study of MCI-196.

A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients ...

A look at the following clinical trial: A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With Hyperphosphatemia.